Advisory Panel

Accounting & Taxation

Larry Walther, Ph.D., CPA, CMADavid George Vequist IV, Ph.D.

Business Fundamentals

Ralph W Flanary, MBA, CFEThomas Coe

Business Strategy

James Richardson, Ph.D.

Career Readiness - Exploring Your Potential

Bob Cohen, MBA

Economics

Brian Kench, Ph.D.Derek Abrams

Entrepreneurship

Craig A. Turner, Ph.D.

Finance

Delvin D. Hawley, Ph.D.

Information Technology

Angelina I. T. Kiser, Ph.D.

International Business

Duane Helleloid, Ph.D.

Operations Management

James J. Stewart, DScPedro M. Reyes, Ph.D.

Org Behavior & HR

Katherine Campbell, Ph.D.

Recent Reviews All Reviews

The Trump-Loving Lawyer Who Won’t Stop Suing Fox News

Douglas Wigdor, a life-long Republican, has risen to prominence as an anti-discrimination lawyer based on his multiple cases against Fox News.

So You Want to Move to the U.S.?

A minor industry has developed in visas through the EB-5 program. The EB-5 program lets immigrants obtain residency visas in exchange for investing at least $500,000 in distressed areas in the United States.

Guarding Big Pharma’s Crown Jewel

AbbVie Inc., the maker of Humira, a biologic treatment for inflammatory diseases, uses a patent thicket strategy to maintain a monopoly over the drug. AbbVie has over 100 patents on Humira, covering manufacturing processes, drug formulation, methods of treatment, and other aspects of the drug.

Hard Rain and Hard Lessons

Lax regulations in the Houston area aggravated the devastation of Hurricane Harvey.

J&J Loses $417 Million Talc Verdict in First California Case

Johnson & Johnson, the world’s largest health care provider, was recently handed a $417 judgment for its failure to warn customers of the link between talc in baby powder and ovarian cancer.

Feedback